(Q79812044)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315171%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Early experience with a hybrid accelerated radiotherapy schedule for locally advanced head and neck cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315171%20AND%20SRC:MED&resulttype=core&format=json

adaptive radiation therapy

26 December 2019

main subject

0 references

advanced head and neck cancer

1 reference

1 reference

head and neck carcinoma

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315171%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Piet Dirix

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315171%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Robert Hermans

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315171%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Vincent Vander Poorten

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315171%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Pierre Delaere

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315171%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Caroline Weltens

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315171%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Walter Van den Bogaert

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315171%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

language of work or name

English

0 references

publication date

1 August 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315171%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315171%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315171%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315171%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

720-730

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17315171%20AND%20SRC:MED&resulttype=core&format=json

Head and neck cancer: a global perspective on epidemiology and prognosis.

26 December 2019

cites work

0 references

Cancer statistics, 2006

1 reference

7 January 2021

Epidemiology of head and neck cancer: magnitude of the problem

1 reference

7 January 2021

Chemotherapy in the management of squamous-cell carcinoma of the head and neck

1 reference

7 January 2021

Medical treatment in head and neck cancer

1 reference

7 January 2021

1 reference

7 January 2021

A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck

1 reference

7 January 2021

Fractionation parameters for human tissues and tumors

1 reference

7 January 2021

Time-dose factors in radiotherapy: a review of the human data.

1 reference

7 January 2021

Radiotherapy for cancer of the head and neck: altered fractionation regimens

1 reference

7 January 2021

Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitations

1 reference

7 January 2021

1 reference

7 January 2021

Hyperfractionated radiotherapy in head and neck cancer: a second look at the clinical data

1 reference

7 January 2021

Does tumor control decrease by prolonging overall treatment time or interrupting treatment in laryngeal cancer?

1 reference

7 January 2021

European Organization for Research on Treatment of Cancer trials using radiotherapy with multiple fractions per day. A 1978-1987 survey

1 reference

7 January 2021

Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma.

1 reference

7 January 2021

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

1 reference

7 January 2021

Very accelerated radiation therapy: preliminary results in locally unresectable head and neck carcinomas

1 reference

7 January 2021

The feasibility of high-dose multiple daily fractionation and its combination with anoxic cell sensitizers in the treatment of head and neck cancer. A pilot study of the Radiotherapy Group of the EORTC (European Organisation for Research on Treatmen

1 reference

7 January 2021

Late results of multiple fractions per day (MFD) with misonidazole in advanced cancer of the head and neck. A pilot study of the EORTC radiotherapy group

1 reference

7 January 2021

Early results of the EORTC randomized clinical trial on multiple fractions per day (MFD) and misonidazole in advanced head and neck cancer

1 reference

7 January 2021

The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: long-term results and side effects

1 reference

7 January 2021

The EORTC randomized trial on three fractions per day and misonidazole in advanced head and neck cancer: prognostic factors

1 reference

7 January 2021

Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial

1 reference

7 January 2021

A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study.

1 reference

7 January 2021

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial

1 reference

7 January 2021

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

7 January 2021

Radiotherapy by multiple fractions per day (MFD) in head and neck cancer: acute reactions of skin and mucosa

1 reference

7 January 2021

Altered fractionation: limited by mucosal reactions?

1 reference

7 January 2021

Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas

1 reference

7 January 2021

Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis

1 reference

7 January 2021

Concomitant low-dose cisplatin and three-dimensional conformal radiotherapy for locally advanced squamous cell carcinoma of the head and neck: Analysis of survival and toxicity

1 reference

7 January 2021

Concomitant chemotherapy and radiation therapy certainly improves local control

1 reference

7 January 2021

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

1 reference

7 January 2021

Concomitant cisplatin and radiotherapy in a conventional and modified fractionation schedule in locally advanced head and neck cancer: a randomised phase II EORTC trial

1 reference

7 January 2021

Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14

1 reference

7 January 2021

French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC).

1 reference

7 January 2021

No age limit for radical radiotherapy in head and neck tumours

1 reference

7 January 2021

Dose-response relationships within the parotid gland after radiotherapy for head and neck cancer

1 reference

7 January 2021

Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer

1 reference

7 January 2021

Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the Radiation Therapy Onc

1 reference

7 January 2021

Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas

1 reference

7 January 2021

A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer

1 reference

7 January 2021

Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.

1 reference

7 January 2021

Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer

1 reference

7 January 2021